On April 30, 2025, Hangzhou Fanttest Biotech (hereinafter referred to as “Fanttest”) announced that its independently developed Helicobacter pylori (H. pylori) diagnostic product has successfully pa...
Most people who contract COVID today will only experience mild symptoms. However, some individuals remain at risk of severe illness and are more likely to be hospitalised. This includes older adults, ...
On April 14, 2025, Hangzhou Fanttest Biotech Co., Ltd. (hereinafter referred to as "Fanttest") announced that its independently developed rapid respiratory diseases combination test kits (6-...
